Stay cautious of market momentum in 2025. Stock picking will be key for value opportunities in overlooked sectors like real ...

BeiGene (BGNE) has received U.S. FDA approval for its cancer drug Tevimbra in combination with chemotherapy for certain ...

W. P. Carey, a well-known REIT, faced investor backlash after raising and quickly cutting its dividend in late 2023 to $0.86.

Despite record leasing and backlog activity, Digital Realty's occupancy rates remain concerning. Read what could be next for ...

Investors are looking for portfolios designed for low volatility and high yield. Read about one strategy that aims for financial stability regardless of market conditions.

JD.com is rated a buy due to its attractive valuation, macroeconomic tailwinds, and potential growth in logistics and autonomous technology. China's e-commerce market struggles, but fiscal and ...

The stock has been trading sideways for the entire 2024, mainly due to stagnant Book Value and ROE. Wealth Management, its main unit, represents 60% of UBS's Revenue, but is still lagging in terms of ...

Netflix dazzles with record-setting ratings for Christmas NFL games. Rigetti leads quantum stocks higher as year-end surge ...

El Pollo Loco's stock price drop to around $11 offers a +25% margin of safety, making it a safer entry point for investors.

GDXU is a 3X Leveraged ETN tracking gold miners. Read here for highlights of risks of inflation, weak commodity prices, and ...

Samsung Electronics plans to reorganize its supply chain for advanced semiconductor packaging to enhance competitiveness and ...

Read thorough research and investment insights by Garvit Bhandari on Seeking Alpha here. View their credentials, investment ...